Management of Metastatic Non-Small-Cell Lung Cancer and a Consideration of Cost
- 1 January 1993
- Vol. 103 (1) , 68S-71S
- https://doi.org/10.1378/chest.103.1_supplement.68s
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1991
- Symptomatic treatmentversus combination chemotherapy for patients with extensive non-small cell lung cancerCancer, 1991
- Recent Outcomes for Patients with Carcinoma of the LungCancer Investigation, 1991
- Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.Journal of Clinical Oncology, 1990
- A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancerBritish Journal of Cancer, 1990
- Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancerBritish Journal of Cancer, 1989
- Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?Cancer, 1989
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- A New International Staging System for Lung CancerChest, 1986
- Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1985